This presentation will focus on variation in medical spending in patients with breast and prostate cancer. Differences in physician practice patterns, the use of advanced technologies and of services that have been identified as low-value by the Choosing Wisely Campaign will be evaluated. The implications of these findings and differences between Canada and the United States will be discussed in terms of recent policy reform efforts.
Danielle Rodin, M.D., M.P.H., F.R.C.P.C., is a radiation oncologist and the Commonwealth Fund’s 2017-2018 Canadian Harkness Fellow in Health Care Policy and Practice. She completed her M.D. and postgraduate specialty training at the University of Toronto, and M.P.H. from Harvard University. She is now undertaking her fellowship in the Department of Health Policy and Management at the Harvard T. H. Chan School of Public Health, where she is identifying approaches to enhance the utilization of value-based cancer care. With that aim, she is analyzing variation in the treatment patterns and costs of specific clinical care pathways for prostate cancer, and the impact of clinical practice guidelines on the use of low-value cancer services for prostate, breast, and hematologic malignancies. Dr. Rodin’s work has been published in Lancet Oncology, Lancet Global Health, and numerous other peer-reviewed journals. She is currently an attending radiation oncologist at Dana Farber/Brigham and Women’s Cancer Center, and will assume a faculty position in radiation oncology at Princess Margaret Cancer Centre in Toronto as of October 2018.